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groups of persons and could lead to 
generation of speciﬁ  c preventive rec-
ommendations.
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Rabies Prophylaxis 
for Pregnant 
Women
To the Editor: Rabies poses a 
100% risk for death to pregnant wom-
en and an indeterminate risk to the 
fetus (1,2). Although a theoretical risk 
exists for adverse effects from rabies 
immune globulin and killed rabies vi-
rus vaccines, several studies assessing 
the safety of this treatment have failed 
to identify these risks (3–6). Indeed, 
the consensus is that pregnancy is not 
a contraindication to rabies postexpo-
sure prophylaxis (PEP) (7). Despite 
this concensus, healthcare providers 
resist treating pregnant women with 
rabies PEP. We describe a case of a 
pregnant woman with uncertain rabies 
exposure.
A 35-year-old pregnant woman 
(at 34 weeks gestation) sought treat-
ment 3 weeks after being exposed to 
a bat. The patient reported awakening 
at 3:00 AM to ﬁ  nd a bat ﬂ  ying in her 
bedroom. She attempted to conﬁ  ne 
the bat to 1 section of the home and 
then called for help. A relative trapped 
and retrieved the bat, then disposed of 
the animal without further incident. 
The patient denied being bitten by 
the bat, and she had no obvious bite 
marks after the event. Initially, the 
patient sought information from on-
line resources, her primary care phy-
sician, and her obstetrician. She was 
uncertain whether rabies PEP was 
warranted, given what she believed to 
be the low probability of the bat be-
ing rabid and the low likelihood of her 
having had direct exposure to the bat. 
The patient did express concern about 
the safety of rabies PEP in pregnant 
women. Because no unequivocal rec-
ommendations were made by either 
her primary care physician or obstetri-
cian, she sought further advice from 
the Infectious Diseases Department 
at the University of Michigan on how 
best to proceed.
The 1999 recommendations of 
Centers for Disease Control and Pre-
vention Advisory Committee on Im-
munization Practices state, “... postex-
posure prophylaxis can be considered 
for persons who were in the same 
room as the bat and who might be un-
aware that a bite or direct contact had 
occurred ...” (8). Bat bites may not be 
apparent when they occur, even with 
careful examination. In fact, most of 
the recent human rabies patients have 
no known history of exposure to a ra-
bid animal (9,10). Of the 21 cases of 
bat-associated rabies in the United 
States during 1980–1999, 12 (57%) 
occurred in persons with apparent bat 
contact but no detectable bites (8). 
Our patient woke up with a bat ﬂ  y-
ing in her room and did not know how 
long it had been there. The best course 
of action would have been to test the 
bat for rabies. However, because the 
animal had already been disposed of, 
laboratory testing for rabies was not 
possible. Furthermore, given that 5%–
9% of bats tested in Washtenaw Coun-
ty, Michigan, are positive for rabies 
(www.mdch.state.mi.us/pha/epi/cded/
cd/batcoframe.htm), the exposure risk 
was not insigniﬁ  cant.  Therefore,  it 
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was our opinion that this patient quali-
ﬁ  ed for rabies PEP.
Several studies of the safety of ra-
bies PEP for pregnant patients demon-
strated no association between treat-
ment and adverse outcomes (3–6). In 1 
study, tissue culture-derived vaccines 
and human immune globulin did not 
lead to an increased risk for congenital 
anomalies; no effects were observed 
on intrauterine or infant growth or 
development with a follow-up period 
of 1 year postpartum (6). Although 
these studies are not comprehensive 
in their assessment of all reproductive 
outcomes, they do suggest that PEP is 
generally safe.
On the basis of the exposure and 
our literature review, we recommend-
ed that the patient receive rabies PEP. 
After discussing options with her hus-
band, the patient chose not to receive 
treatment, citing continued concern 
about the effect of rabies PEP on the 
fetus. There must be a greater public 
health effort to educate clinicians and 
the public about proper response to bat 
exposures, particularly undetectable 
bite exposures such as this case. Had 
public health authorities been contact-
ed to collect and test the captured bat 
for rabies, there would have been no 
ambiguity as to the appropriate course 
of action.
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Novel Orthoreovirus 
from Diseased 
Crow, Finland 
To the Editor: Corvids, especial-
ly American crows (Corvus brachy-
rhynchos), are reported to be highly 
susceptible to lineage 1 of West Nile 
virus (WNV), which causes them to 
show symptoms of encephalitis. They 
are regarded as indicator species in the 
surveillance of WNV in the United 
States (1). In parts of Europe, WNV 
is endemic and studies are ongoing to 
detect WNV in wild birds. Thus far, 
no evidence of WNV in birds has been 
found in northern Europe.
 In August 2002, in southern Fin-
land, a diseased wild hooded crow 
(Corvus corone cornix) was found 
ﬂ   ying abnormally with coordination 
problems, abnormal postures, cramps, 
and paralysis. Because WNV infection 
was suspected, virologic tests were 
performed, which resulted in the iso-
lation of a novel orthoreovirus, which 
was likely the causative agent of the 
disease.
Avian orthoreoviruses (ARVs) 
belong to the family Reoviridae, ge-
nus  Orthoreovirus. They infect wild 
and farm-raised  birds and are im-
portant fowl pathogens associated 
with various disease conditions such 
as gastrointestinal malabsorption 
syndrome, tenosynovitis (arthritis), 
growth retardation, and sudden death. 
They have also been isolated from 
asymptomatic birds. The reovirus vi-
rion is icosahedral, nonenveloped, 
and has a double-capsid structure 
that shelters the segmented double-
stranded RNA genome (2).
Heart, lung, liver, kidney, and 
brain tissues of the diseased crow 
tested negative for WNV RNA. Virus 
isolation from brain homogenate was 
carried out in BHK (baby hamster 
kidney)–21 cells. On day 2 after in-
fection, a strong cytopathic effect was 
observed, including syncytium forma-
tion. Spherical, spiked virus particles, 
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Letters
Letters commenting on recent articles as 
well as letters reporting cases, outbreaks, 
or original research are welcome. Letters 
commenting on articles should contain no 
more than 300 words and 5 references; they 
are more likely to be published if submit-
ted within 4 weeks of the original article’s 
publication. Letters reporting cases, out-
breaks, or original research should contain 
no more than 800 words and 10 references. 
They may have one Figure or Table and 
should not be divided into sections. All let-
ters should contain material not previously 
published and include a word count.